Happy Poster
Type:
Happy Poster
Category:
Happy Poster
Place:
Arena Científica
Date and time:
22:10 to 23:10 on 06/06/2024
Share your questions or ideas about this activity!
Papers
PANEL 1
Autoimmune Limbic Encephalitis Presenting with Fasciobrachial Dystonic Seizures: A Case Report
PANEL 2
Concomitant MOG-related optic neuritis and conus medullaris involvement: a case report
PANEL 3
Bilateral MOG-related optic neuritis after Varicella Zoster reactivation: a case report
PANEL 4
Cervical Spondylotic Myelopathy in the differential diagnosis of Autoimmune Myelitis
PANEL 5
CHRONIC SPONTANEOUS URTICARIA DURING NATALIZUMAB THERAPY IN A PATIENT WITH MULTIPLE SCLEROSIS: A CASE REPORT
PANEL 6
Atopic myelitis as a differential diagnosis of demyelinating diseases: a case report.
PANEL 7
Beyond neurology: dermatological manifestations in the prodromal phase of multiple sclerosis
PANEL 8
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
PANEL 9
Assessment of Cognitive Function and Fatigue in Multiple Sclerosis
PANEL 10
Description of Symptoms in the Latest Multiple Sclerosis Relapse in the Elderly Population
PANEL 11
Anxiety and Depression in Multiple Sclerosis: prevalence and associated factors
PANEL 12
Challenges in diagnosing multiple sclerosis: case report of pseudotumor lesion presentation
PANEL 13
Beyond Conventional Scales: A Critical Reflection on the Diagnosis of Depression and Fatigue in Multiple Sclerosis
PANEL 14
Neurological presentation of sarcoidosis
PANEL 15
Systemic Autoimmunity in a Multiple Sclerosis Patient - Thyroid and Liver Overlap
PANEL 16
EVALUATION OF MRI FINDINGS ASSOCIATED WITH WORSE PROGNOSIS IN BENIGN MULTIPLE SCLEROSIS PATIENTS
PANEL 17
Synthetic MRI in progressive MS: associations with disability
PANEL 18
Quantitative evaluation of remyelination in patients with Multiple Sclerosis and its correlation with quality of life and functionality
PANEL 19
Cognitive-Behavioral Syndrome, a diagnostic challenge in NMOSD. The Arch Bridge Pattern can Help.
PANEL 20
Antibody-mediated demyelinating disease – A voxel-based morphology analysis
PANEL 21
Preliminary data on importance of susceptibility imaging in the diagnosis of multiple sclerosis
PANEL 22
The Value of Iron Imaging and Central Vein Sign in the Diagnostic and Follow-up of Multiple Sclerosis
PANEL 23
Association between myelin content variation and clinical-radiological activity in multiple sclerosis
PANEL 24
Diffusion tensor imaging findings related to disability and quality of life in multiple sclerosis: a 12 years follow-up
PANEL 25
Time between the first symptom, diagnosis and treatment of multiple sclerosis in a brasilian cohort. The impact of early diagnosis.
PANEL 26
PREVALENCE OF TRIGEMINAL NEURALGIA IN A NORTHEAST TERTIARY MULTIPLE SCLEROSIS REFERENCE CENTER
PANEL 27
EVALUATION OF PARAMETERS AND PROGNOSIS FACTORS ASSOCIATED WITH BENIGN EVOLUTION OF MULTIPLE SCLEROSIS PATIENTS
PANEL 29
From Water Pores to Aquaporins. A History of Human Discoveries… and Controversies
PANEL 30
Strongyloidiasis prophylaxis: Ivermectin in neurological patients undergoing immunosuppressive treatment
PANEL 31
Profile of infusion-associated reactions with Alemtuzumab in a Brazilian reference center.
PANEL 32
Nonalcoholic steatohepatitis as an important differential diagnosis for drug-induced liver injury in patients using fingolimod – a case report.
PANEL 33
Real-world experience with patient laboratory monitoring compliance during Alemtuzumab treatment in a low-income country: A pilot descriptive study
PANEL 34
Hyperkeratotic lesions associated to Natalizumab treatment for multiple sclerosis: Case report and literature review
PANEL 35
Assessment of Visual Perception and Impact of the Use of High-Efficacy Medications in Patients
PANEL 36
Exploring the Impact of Physical Exercise on Cognitive Function in Multiple Sclerosis: A Systematic Review and Meta-analysis.
PANEL 37
Modifying disease therapy in multiple sclerosis and breast cancer: case report
PANEL 38
Breaking Through the Storm: combination therapy with Ocrelizumab and Cyclophosphamide in an unusual and severe case of Multiple Sclerosis
PANEL 39
Discontinuation of Disease Modifying Drugs in Older Multiple Sclerosis Patients with Stable Disease: A Retrospective Observational Study
PANEL 40
Challenges in the Differential Diagnosis of Leptomeningeal Involvement in Patients with Multiple Sclerosis: A Case Report of Occipitotemporal Leptomeningeal Lesion
PANEL 41
Exit strategies in Natalizumab: the dilemma in limited resource scenarios.
PANEL 42
Translation and Validation of the Multiple Sclerosis Knowledge Assessment Scale for Use in Brazil
PANEL 43
How Much Do Brazilian Multiple Sclerosis Patients Know About Their Disease? A MSKAS-Based Study
PANEL 44
"The Group's Waiting Room": A Successful Experience in the Outpatient Clinic for Demyelinating Diseases
PANEL 45
Infusional therapies in multiple sclerosis and neuromyelitis optica: long-term experience from a specialized neurological infusional therapy center from a university hospital in Rio de Janeiro
PANEL 46
Use of mobile app to monitoring patients with multiple sclerosis
PANEL 47
Weston-Hurst syndrome, how to recognize - a case report
PANEL 48
Optic Neuritis as an Initial Presentation of Granulomatosis with Polyangiitis: Two Case Reports
PANEL 49
Looking Beyond Optic Disc Drusen: The Concealment of Relapsing Isolated Optic Neuritis
PANEL 50
Functional Disability of Neuromyelitis Optica Spectrum Disorder in Brasil
PANEL 51
Sociodemographic Profile of Neuromyelitis Optica Spectrum Disorder in Brasil
PANEL 52
RETINAL EVALUATION WITH SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY IN EYES WITH PREVIOUS OPTIC NEURITIS AND NEUROMYELITIS OPTICA SPECTRUM DISORDERS OR ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIDOBY ASSOCIATED DISEASE
PANEL 53
MOG-IgG is Rare in AQP4-IgG Seronegative NMOSD in Brazil. Insights from a Single-Center Cohort
PANEL 54
Susac syndrome: remind to see and hear
PANEL 55
Water Channelopathies Beyond NMOSD: A Pathophysiological Discussion on Two Real World Clinical Cases
PANEL 56
Exploring the Relationship Between Ibrutinib Therapy and Neuromyelitis Optica Spectrum Disorders: A case report
PANEL 57
Brain lesions characteristic of NMOSD and the impact of treatment on radiological evolution: a case report.
PANEL 58
Evaluation of neuromyelitis optica spectrum disorder in patients under Rituximab and applicability of no responsiveness criteria for first-line therapies: A real-world data in resources limited settings
PANEL 59
Pediatric Patient with Acute Disseminated Encephalomyelitis with Characteristic MRI Images of Multiple Sclerosis
PANEL 60
![[object Object]](https://static.galoa.com.br/file/Eventmanager-Private/styles/attendee_dashboard_logo/s3/eventmanager_event/logo/Logo_31.png?VersionId=4_z9e083e414507696175f50716_f1111809d7fab9f12_d20240213_m140544_c003_v0312024_t0055_u01707833144955&itok=6Ntafve0 "[object Object]"){kind=logo}
